Bryn Mawr Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bryn Mawr Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$915K	Sell	10,125 -29,699	-75%	-$2.73M	0.04%	219
2025 Q4	$3.58M	Sell	39,824 -25,448	-39%	-$2.41M	0.17%	115
2025 Q3	$6.43M	Buy	65,272 +2,030	+3%	+$201K	0.32%	79
2025 Q2	$5.77M	Buy	63,242 +5,229	+9%	+$506K	0.32%	80
2025 Q1	$6.57M	Buy	58,013 +8,730	+18%	+$934K	0.39%	68
2024 Q4	$5.21M	Sell	49,283 -2,929	-6%	-$314K	0.28%	81
2024 Q3	$5.64M	Sell	52,212 -25,619	-33%	-$2.8M	0.3%	78
2024 Q2	$8.45M	Buy	77,831 +3,543	+5%	+$418K	0.47%	55
2024 Q1	$9.8M	Buy	74,288 +4,918	+7%	+$614K	0.56%	48
2023 Q4	$8.44M	Sell	69,370 -245	-0.4%	-$27.3K	0.53%	47
2023 Q3	$7.81M	Buy	69,615 +7,603	+12%	+$966K	0.51%	47
2023 Q2	$9.03M	Buy	62,012 +819	+1%	+$111K	0.85%	30
2023 Q1	$7.91M	Sell	61,193 -1,990	-3%	-$250K	0.82%	32
2022 Q4	$8.06M	Buy	+63,183	New	+$7.33M	0.87%	32

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bryn Mawr Capital Management's ZBH Position: Q1 2026 in Review

Bryn Mawr Capital Management reduced its Zimmer Biomet (ZBH) stake by 75% in Q1 2026, selling an estimated $2.73M and leaving 10,125 shares worth $915K. The position accounts for 0.04% of the portfolio, ranked #219.

Bryn Mawr Capital Management first reported a position in ZBH in Q4 2022 and has held it in 14 quarters since. The position peaked at $9.8M in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Bryn Mawr Capital Management held 10,125 shares of Zimmer Biomet worth $915K as of Q1 2026.
Bryn Mawr Capital Management sold 29,699 Zimmer Biomet shares in Q1 2026, an estimated $2.73M.
Zimmer Biomet made up 0.04% of Bryn Mawr Capital Management's portfolio in Q1 2026, its #219 holding.
Bryn Mawr Capital Management first reported a position in Zimmer Biomet in Q4 2022 and has held it in 14 quarters since.
Bryn Mawr Capital Management's Zimmer Biomet position peaked at $9.8M in Q1 2024.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2026, filed 4 May 2026.